Notice Regarding the Delivery of Authenticated Publication Lists

Due to a global Microsoft service outage, Outlook is currently unavailable, including our email address publikaciok@lib.unideb.hu.

As a result, the delivery of authenticated publication lists is temporarily suspended, unfortunately affecting several requests with deadlines today.

Once email services are restored, we will prioritise the delivery of time-sensitive lists.

Thank you for your patience and understanding!

Erdei Annamária

University of Debrecen Faculty of Medicine

Department of Internal Medicine

2001-

University of Debrecen Faculty of Medicine

Department of Internal Medicine

Division of Endocrinology

2021-

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2004-2026

2026

Erdei, A., Blasszauer, C., Komka, I., Szkibák, N., Nagy, E. V., Berta, E., Nagy, Z., Tóth, M., Tőke, J., Lakatos, P., Mészáros, S., Reismann, P., Kovács, G. L., Hubina, E., Solymosi, T., Csajbók, É., Sepp, K., Valkusz, Z., Fulcz, Á., Rakk, E., Major, J., Mezei, P., Szujó, S., Gulyás, E., Horváth, K., Nagy, G., Papp, Z., Erhardt, É., Molnár, J., Luczay, A., Mezősi, E.: A pajzsmirigyrák valós életbeli, retrospektív vizsgálata a hazai gyakorlat feltérképezésére.
Orv. hetil. 167 (37), 1468-1476, 2026.

doi DEA WoS Scopus

Journal metrics:

Q4 Medicine (miscellaneous) (2025)

Köröskényi, L., Szkibák, N., Steiber, Z., Barna, S., Nagy, E., Karányi, Z., Balla, J., Bodor, M., Nagy, E. V., Erdei, A.: Pegvisomant in severe, treatment-resistant thyroid eye disease: a case report.
Drugs Context. 15, 1-8, (article identifier: 2026), 2026.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous) (2025)

Q3 Molecular Medicine (2025)

Q2 Pharmacology (2025)

Katkó, M., Gazdag, A., Szentpéteri, A., Lőrincz, H., Galgóczi, E., Erdei, A., Berta, E., Bodor, M., Nagy, E. V., Harangi, M.: The Effect of Iatrogenic Hypothyroidism on Lipoprotein Subfractions and Markers of HDL Function in Patients with Differentiated Thyroid Carcinoma.
Life. 16 (7), 1-14, (article identifier: 1083), 2026.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2025)

Q1 Ecology, Evolution, Behavior and Systematics (2025)

Q1 Paleontology (2025)

Q2 Space and Planetary Science (2025)

2025

Ratku, B., Lőrincz, H., Csiha, S., Biró, L., Erdei, A., Berta, E., Ujvárosy, D., Bodor, M., Nagy, E. V., Szabó, Z., Harangi, M., Somodi, S.: Alterations of lipoprotein subfractions in GH-deficient adults.
Front Endocrinol (Lausanne). 16, 1-14, 2025.

doi DEA

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism

van de Berg, D. J., Vriens, M. R., van Santen, H. M., Seur, A., Clement, S. C., van Trotsenburg, A. S. P., Bruinstroop, E., Kruijff, S., Peeters, R. P., Verburg, F. A., Netea-Maier, R., Jamaludin, F. S., Nieveen van Dijkum, E. J. M., Derikx, J. P. M., Engelsman, A. F., Thyroid Surgery COS Collaboration Group: Core Outcome Set of the Surgical Treatment of Differentiated Thyroid Carcinoma: International Consensus by Delphi Study.
Thyroid. 35 (12), 1412-1421, 2025.

doi DEA WoS Scopus

Erdei, A.: Gyógyszerek endokrin mellékhatásai.
In: Endokrin betegségek felnőttkorban. Szerk.: Nagy V. Endre, Medicina Könyvkiadó Zrt., Budapest, 240-243, 2025. ISBN: 9789632268057

DEA

van de Berg, D. J., van Santen, H. M., Clement, S. C., Vriens, M. R., van Trotsenburg, A. S. P., Bruinstroop, E., Kruijff, S., Peeters, R. P., Verburg, F. A., Netea-Maier, R., Nieveen van Dijkum, E. J. M., Fugazzola, L., Dedecjus, M., Visser, W. E., Baidoo, K. K., Derikx, J. P. M., Engelsman, A. F., Differentiated Thyroid Cancer Recurrence Collaboration Group: International Consensus on the Requirements for Definitions of Complete Remission and Recurrence of Differentiated Thyroid Cancer: a Delphi Study (ICON-DTC).
Eur. J. Endocrinol. 193 (6), 772-782, 2025.

doi DEA WoS Scopus

Makhoul, S., Aranyosi, J. K., Csiki, E., Urbancsek, H., Nagy, E. B., Erdei, A., Fodor, M., Kovács, Á., Nagy, E. V., Ujhelyi, B.: No retinopathy after orbital irradiation in patients with thyroid eye disease: a follow up study.
Front Endocrinol (Lausanne). 16, 1-6, (article identifier: 1720650), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism

2024

Papp, F. R., Katkó, M., Csiki, R., Galgóczi, E., Molnár, Z., Erdei, A., Bodor, M., Steiber, Z., Ujhelyi, B., Nagy, E. V.: Characteristics of Hyaluronan Metabolism During Myofibroblast Differentiation in Orbital Fibroblasts.
Invest. Ophthalmol. Vis. Sci. 65 (13), 1-12, (article identifier: 13), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Cellular and Molecular Neuroscience

Q1 Ophthalmology

Q1 Sensory Systems

2023

10.

Ratku, B., Borbásné Sebestyén, V., Szelesné Árokszállási, A., Erdei, A., Berta, E., Szabó, Z., Bodor, M., Nagy, E. V., Somodi, S.: A felnőttkori növekedésihormon-hiány szív- és érrendszeri szövődményei.
Orv. hetil. 164 (41), 1616-1627, 2023.

doi DEA WoS Scopus

Journal metrics:

Q4 Medicine (miscellaneous)

11.

Erdei, A., Ménes, E., Emri, G.: Endocrine side effects of immune-checkpoint inhibitors in patients with malignant melanoma.
Endocrine Abstracts. 90, EP678, 2023.

doi DEA

12.

Dániel, E., Nagy, B. E., Nagy, E. V., Erdei, A.: Kezelés nélkül javuló acromegalia a pandémia alatt.
Metabolizmus. 21 (2), 86-89, 2023.

DEA

2022

13.

Frendl, I., Erdei, A., Zsíros, N., Katkó, M., Galgóczi, E., Németi, Z., Bhattoa, H. P., Kappelmayer, J., Posta, J., Turchányi, B., Urbán, F., Nagy, E. V.: Alcohol consumption affects the late endocrine consequences of mild traumatic brain injury.
Neuroendocrinol. Lett. 43 (4), 239-245, 2022.

DEA WoS Scopus

Journal metrics:

Q4 Endocrine and Autonomic Systems

Q4 Endocrinology

Q4 Endocrinology, Diabetes and Metabolism

Q4 Medicine (miscellaneous)

Q4 Neurology

Q4 Neurology (clinical)

Q4 Psychiatry and Mental Health

14.

Erdei, A., Dániel, E., Gazdag, A., Griger, M., Nagy, E. B., Nagy, E. V.: Cessation of GH secretion in acromegaly without medical or surgical intervetion: Covid-postponed surgery was escaped.
Endocrine Abst. 81, EP704, 2022.

DEA

15.

Aranyosi, J. K., Galgóczi, E., Erdei, A., Katkó, M., Fodor, M., Ujhelyi, Z., Bácskay, I., Nagy, E. V., Ujhelyi, B.: Different Effects of Cigarette Smoke, Heated Tobacco Product and E-Cigarette Vapour on Orbital Fibroblasts in Graves' Orbitopathy; a Study by Real Time Cell Electronic Sensing.
Molecules. 27 (9), 1-14, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

16.

Ratku, B., Borbásné Sebestyén, V., Erdei, A., Nagy, E. V., Szabó, Z., Somodi, S.: Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile.
Pituitary. 25 (2), 211-228, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Endocrinology

Q2 Endocrinology, Diabetes and Metabolism

17.

Erdei, A.: G4-immunglobulinnal társult endokrin betegségek.
Orv. hetil. 163 (30), 1175-1180, 2022.

doi DEA WoS Scopus

Journal metrics:

Q4 Medicine (miscellaneous)

18.

Galgóczi, E., Katkó, M., Papp, F. R., Csiki, R., Csiha, S., Erdei, A., Bodor, M., Ujhelyi, B., Steiber, Z., Győry, F., Nagy, E. V.: Glucocorticoids Directly Affect Hyaluronan Production of Orbital Fibroblasts: a Potential Pleiotropic Effect in Graves' Orbitopathy.
Molecules. 28 (1), 1-12, (article identifier: 15), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

19.

Erdei, A., Gazdag, A., Ujhelyi, B., Nagy, E. B., Berényi, E., Berta, E., Steiber, Z., Barna, S., Mezősi, E., Bodor, M., Nagy, E. V.: Non-surgical orbital decompression using diuresis in dysthyroid optic neuropathy: a case report.
Eur. Thyroid J. 11 (5), 1-10, (article identifier: 220078), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Endocrinology, Diabetes and Metabolism

20.

Galgóczi, E., Katkó, M., Erdei, A., Bodor, M., Ujhelyi, B., Steiber, Z., Győry, F., Nagy, E. V.: The effect of glucocorticoids on hyaluronan production of orbital fibroblasts.
Endocrine Abst. 84, PS2-07-64, 2022.

doi DEA

21.

Katkó, M., Gazdag, A., Harangi, M., Szentpéteri, A., Galgóczi, E., Erdei, A., Berta, E., Bodor, M., Bhattoa, H. P., Nagy, E. V.: The effect of iatrogenic hypothyroidism on lipoprotein subfractions and serum paraoxonase activity in patients with differentiated thyroid cancer.
Atherosclerosis. 355, e163, 2022.

doi DEA

2021

22.

Erdei, A.: Endokrin orbitopathia.
Orvostovábbk. szle. 28 (1), 1-7, 2021.

DEA

23.

Erdei, A.: Gyógyszerek endokrin mellékhatásai.
In: Endokrin betegségek felnőttkorban. Szerk.: Nagy V. Endre, Medicina Könyvkiadó Zrt., Budapest, 240-242, 2021.

DEA

24.

Katkó, M., Galgóczi, E., Erdei, A., Gazdag, A., Berta, E., Bodor, M., Seres, I., Hircsu, I., Badics, Á., Ujhelyi, B., Sira, L., Bhattoa, H. P., Nagy, E. V.: The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease.
J. Inflamm. Res. 14, 1883-1890, 2021.

doi DEA

Journal metrics:

Q2 Immunology

Q2 Immunology and Allergy

2020

25.